SCHEMBL6432242

SCHEMBL6432242

CC1CCC2C(CCC3CC(=O)C=CN32)C1

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.45
SRD5A1 P18405 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6431812 0.82 SRD5A2 (0.42) SRD5A2SRD5A1
SCHEMBL6431503 0.80 SRD5A2 (0.47) SRD5A2SRD5A1
SCHEMBL6431907 0.80 SRD5A2 (0.47) SRD5A2SRD5A1
SCHEMBL6435004 0.80 SRD5A2 (0.47) SRD5A2SRD5A1
SCHEMBL6431975 0.79 SRD5A1 (0.34) SRD5A2SRD5A1
SCHEMBL6432320 0.78 SRD5A2 (0.44) SRD5A2SRD5A1
SCHEMBL6436318 0.76 SRD5A1 (0.38) SRD5A1
SCHEMBL7888454 0.76 SRD5A1 (0.38) SRD5A1
SCHEMBL6434180 0.72
SCHEMBL6431351 0.71 SRD5A2 (0.40) SRD5A2SRD5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962925-B1 Benzo(C)quinolizine derivatives and their use as 5α-reductases inhibitors APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-11-08 US claimed
EP-1066284-B1 BENZO(C)QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS APPLIED RESEARCH SYSTEMS (AN) 2005-08-31 EP claimed
EP-1066284-A1 BENZO C]QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS Applied Research Systems ARS Holding N.V. (AN) 2001-01-10 EP claimed
WO-1999033828-A1 BENZO[C]QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 1999-07-08 WO claimed
EP-0926148-A1 Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 1999-06-30 EP claimed
US-6962925-B1 Benzo(C)quinolizine derivatives and their use as 5α-reductases inhibitors APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-11-08 US disclosed
EP-1066284-B1 BENZO(C)QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS APPLIED RESEARCH SYSTEMS (AN) 2005-08-31 EP disclosed
EP-1066284-A1 BENZO C]QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS Applied Research Systems ARS Holding N.V. (AN) 2001-01-10 EP disclosed
WO-1999033828-A1 BENZO[C]QUINOLIZINE DERIVATIVES AND THEIR USE AS 5 ALPHA-REDUCTASES INHIBITORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 1999-07-08 WO disclosed
EP-0926148-A1 Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 1999-06-30 EP disclosed